Biogen Says Physician Debate About Aduhelm More ‘Pervasive’ Than Anticipated

Lilly Optimistic About Donanemab Opportunity At Citi Event

 
• By Mandy Jackson
  
Conflicting people surrounded by spectators
Biogen is moving forward with publications to reduce doctor debates about Aduhelm • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip